Tel-Aviv, Israel-based RedHill Biopharma entered into a licensing agreement with Carcy, N.C.-based Entera Hill for its EnteraGam.
GI & Endoscopy
The American Gastroenterology Association issued best practices on long term proton pump inhibitor use.
A study published in The American Journal of Gastroenterology examined cholecystectomy's effectiveness in preventing recurrent pancreatitis.
Senior Vice President and General Manager of Bridgewater, N.J.-based Salix Pharmaceuticals Mark McKenna is dedicated to revolutionizing gastroenterology and preventing GI diseases.
Mark Lowe, MD, is a gastroenterologist and the vice chair of clinical affairs and strategic planning at Washington University School of Medicine at St. Louis.
Advertisement
Laval, Canada-based Valeant Pharmaceuticals saw its share price drop 23 percent in March 2017, The Motley Fool reports.
Osaka, Japan-based Takeda and Somerville, Mass.-based Finch Therapeutics entered into a global collaboration agreement to develop FIN-524, a synthetic microbiome therapy for inflammatory bowel disease.
Westport, Conn.-based Lumendi added five regional sales managers to its staff.
Washington University School of Medicine in St. Louis tapped Mark Lowe, MD, to be its vice chair of clinical affairs and strategic planning.
Amy S. Oxentenko, MD, is a gastroenterologist at Rochester, Minn.-based Mayo Clinic.